NINGBO INNO PHARMCHEM CO.,LTD. is proud to highlight Finerenone (CAS 1050477-31-0), a pharmaceutical chemical offering a non-steroidal solution for cardiorenal protection and treatment.

Finerenone functions as a selective non-steroidal mineralocorticoid receptor (MR) antagonist. Its unique, non-steroidal structure allows for potent and targeted inhibition of the MR, thereby mitigating the harmful effects of aldosterone. This selectivity is critical, as it minimizes interactions with other steroid receptors, leading to a superior safety and tolerability profile compared to traditional steroidal MRAs. This is a key aspect of the finerenone mechanism of action.

The compound is highly valued for its therapeutic applications, particularly in managing conditions such as finerenone for diabetic kidney disease. By reducing inflammation and fibrosis within the kidneys, Finerenone helps to slow disease progression and preserve kidney function in individuals with type 2 diabetes.

In the context of cardiovascular health, finerenone benefits heart failure by alleviating cardiac fibrosis and inflammation, leading to improved cardiac function and a reduced risk of adverse cardiovascular events. The comprehensive data from finerenone clinical trials consistently supports its efficacy in these areas.

Understanding the finerenone chemical properties is essential for its optimal use in pharmaceutical development. NINGBO INNO PHARMCHEM CO.,LTD. supplies Finerenone with guaranteed high purity, ensuring its suitability for rigorous research and manufacturing processes. We enable clients to reliably purchase Finerenone for their critical applications.

As a leading supplier, NINGBO INNO PHARMCHEM CO.,LTD. is committed to supporting the pharmaceutical industry's pursuit of better patient outcomes. Whether you are looking to order Finerenone or explore its potential, we provide the quality and reliability you need.